Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Efficacy should drive atypical antipsychotic treatment.

× No keyword cloud information.

6 in total

1. Incident diabetes associated with antipsychotic use in the United Kingdom general practice research database.

Authors: Cynthia J Kornegay; Catherine Vasilakis-Scaramozza; Hershel Jick
Journal: J Clin Psychiatry Date: 2002-09 Impact factor: 4.384

2. Differential effects of risperidone, olanzapine, clozapine, and conventional antipsychotics on type 2 diabetes: findings from a large health plan database.

Authors: Frank D Gianfrancesco; Amy L Grogg; Ramy A Mahmoud; Ruey-hua Wang; Henry A Nasrallah
Journal: J Clin Psychiatry Date: 2002-10 Impact factor: 4.384

3. Clozapine use and risk of diabetes mellitus.

Authors: Philip S Wang; Robert J Glynn; David A Ganz; Sebastian Schneeweiss; Raisa Levin; Jerry Avorn
Journal: J Clin Psychopharmacol Date: 2002-06 Impact factor: 3.153

4. Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach.

Authors: B C Lund; P J Perry; J M Brooks; S Arndt
Journal: Arch Gen Psychiatry Date: 2001-12

5. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia.

Authors: Michael J Sernyak; Douglas L Leslie; Renato D Alarcon; Miklos F Losonczy; Robert Rosenheck
Journal: Am J Psychiatry Date: 2002-04 Impact factor: 18.112

6. Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study.

Authors: Carol E Koro; Donald O Fedder; Gilbert J L'Italien; Sheila S Weiss; Laurence S Magder; Julie Kreyenbuhl; Dennis A Revicki; Robert W Buchanan
Journal: BMJ Date: 2002-08-03

6 in total